“By removing the price negotiation requirement, it will be even more important for manufacturers to develop their optimal pricing strategy in Indonesia.”

Ilham Hidayattulah
Principal Consultant
Asia Actual Indonesia

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Important Documents and Links Related to the eCatalogue

Sign Up For Our Newsletter to Stay Informed

Sign Up

Indonesia Revamps eCatalogue Procurement System

Published on: March 12th, 2022

Updated on: April 11th, 2022

Indonesia Announces Open Enrollment for eCatalogue Procurement System

Latest Update

On April 7th the Ministry of Health announced a new eCatalogue open enrollment policy whereby manufacturers can submit new applications year round. Applications are now accepted upon submission with on-line publication the same or next day. There’s no advanced verification of application documents but application documents are subject to review post publication, and subject to de-listings if anything is found to be incorrect.

A major rework of the eCatalogue system was just implemented in February of 2022 (see associated article here). While the software platform itself seems to be struggling to keep up with increased demand for new listings with frequent “suspension of service” reports, the Ministry of Health has been tweaking the enrollment policies. The latest being the third and most liberal in the past 8 weeks.

Summary of Structural Changes to the e-Catalogue System

On February 11th, the Indonesia government implemented significant structural and procedural changes to the medical device sector of the procurement system known as e-Catalogue (Announcement KN.01.04/3/630/2022). The changes go a long way to increasing ease of access and should be welcomed by hospitals, healthcare works and medical device manufacturers.

Summary of Changes:

  1. E-Catalogue pricing determined solely by manufacturer
  2. Increase the number of device categories that can apply
  3. Increase the length of time the application window is open
  4. Application simplification
  5. Decreases categorization discrepancies with Import License

Perhaps the most significant change is that manufacturers or their local agents are now able to set their own product price in e-Catalogue. Previously, pricing was set through negotiations with the LKPP, or MOH which restricted the price to a controlled markup from landed cost.  Elimination the price negotiation meeting gives full price control to the manufacturer; and is a key element to getting more products on the system faster. In fact, in a speech on February 11th, the Minister of Health set a target of 20,000 products to be included in the e-catalog by June 2022 in support of presidential reformations.

Product categories specified for 2022 enrollment has been expanded to 1,482 types of medical devices.  The enrollment window will be open from February 11th to November 2nd, 2022, with a target of 20,000 products listed by summer 2022.

Structurally, medical device listing in e-Catalogue will be moved to a new Healthcare Sector administration of which will be done by the Ministry of Health. Sectorial administration comes with a simplify application process. Importantly, the requirement for any documents to be Authenticated by the Indonesian Embassy in the country of origin has been eliminated. This will significantly reduce the time for application preparation. Also, with application review by Ministry of Health staff, and no longer by the Indonesian Government Goods and Services Procurement Organization (LKPP), discrepancies between product categorization between the Import License and c-Catalogue application will be eliminated.

Access to the Healthcare Sector is still done via the existing e-catalog portal (, but now there are options to access ‘national’, as well as new ‘sectoral’ and ‘local’ sub-sties.  Any medical devices currently listed on e-Catalogue irrespective of these changes.

What is Indonesia’s e-Catalogue System?

Indonesia’s e-Catalogue is a central purchasing portal used by all government organizations to purchase goods. Initiated in 2013, the system was established to bring transparency and prevent corruption in the government procurement sector, including public hospitals. It took parties some time to understand the implications on sales and at first international and local companies seemed weary to participate in the voluntary system. Eventually, the benefits of listing in the e-Catalogue became obvious and there was a rush on listings, creating delays during the short annual enrollment windows.

It will be important for manufacturers to develop and implement an optimal e-catalogue pricing strategy.

Contact Asia Actual with questions or support requests for our experienced, bi-lingual staff in Jakarta.

Come Grow With Us

Asia Actual works closely with clients to optimize pricing and obtain the fastest eCatalogue listing for your devices. Contact Asia Actual to see if our Indonesia eCatalogue Strategy and Registration services are right for your business. Asia Actual has offices staffed by experienced, bilingual regulatory and commercial professionals in the major capital cities of Asia including Jakarta.

Blog Posts

Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Thai FDA Documentation Exemptions for Concise and Full Regulatory Pathways

Thai FDA Regulatory Documentation Exemptions

March 12, 2024: the Thai FDA released draft guidance updating the list of required documentation for Full and Concise Evaluation. For manufacturers registering a medical device in Thailand, certain documents are no longer required.
Hong Kong MDD adds Singapore HSA to Reference Country List

Hong Kong MDD Adds Singapore as Reference Country

Starting April 2nd, 2024, the Hong Kong Medical Device Division (MDD) accepts, on a regular basis, the marketing approvals obtained from the the Health Sciences Authority (HSA) of Singapore as a support of compliance of medical device to the "Essential Principles of Safety and Performance of Medical Devices" (Technical Reference: TR-004) under MDACS.